Key result
Macrophage vitamin D receptor signaling inhibits atherosclerosis in mice, in part by suppressing the local renin-angiotensin system.
Macrophage vitamin D receptor signaling inhibits atherosclerosis in mice, partially through the suppression of the local renin-angiotensin system.
Answers are grounded in this paper and cite their sources.
Should not yet change clinical practice in atherosclerosis; hypothesis-generating for macrophage VDR targeting in humans.
Although vitamin D has been implicated in cardiovascular protection, few studies have addressed the role of vitamin D receptor (VDR) in atherosclerosis. Here we investigate the effect of inactivation of the VDR signaling on atherogenesis and the antiatherosclerotic mechanism of vitamin D. Low density lipoprotein receptor (LDLR)(-/-)/VDR(-/-) mice exhibited site-specific accelerated atherogenesis, accompanied by increases in adhesion molecules and proinflammatory cytokines in the aorta and cholesterol influx in macrophages. Macrophages showed marked renin up-regulation in the absence of VDR, and inhibition of renin by aliskiren reduced atherosclerosis in LDLR(-/-)/VDR(-/-) mice, suggesting that the renin-angiotensin system (RAS) promotes atherosclerosis in the absence of VDR. LDLR(-/-) mice receiving LDLR(-/-)/VDR(-/-) BMT developed larger lesions than LDLR(-/-) BMT controls. Moreover, LDLR(-/-) mice receiving Rag-1(-/-)/VDR(-/-) BMT, which were unable to generate functional T and B lymphocytes, still had more severe atherosclerosis than Rag-1(-/-) BMT controls, suggesting a critical role of macrophage VDR signaling in atherosclerotic suppression. Aliskiren treatment eliminated the difference in lesions between Rag-1(-/-)/VDR(-/-) BMT and Rag-1(-/-) BMT recipients, indicating that local RAS activation in macrophages contributes to the enhanced atherogenesis seen in Rag-1(-/-)/VDR(-/-) BMT mice. Taken together, these observations provide evidence that macrophage VDR signaling, in part by suppressing the local RAS, inhibits atherosclerosis in mice.
No takes yet. Share an insight, caveat, or question.
Szeto et al. (2012) studied Atherosclerosis. Vitamin D Receptor (VDR) deletion and Aliskiren vs. VDR intact controls and untreated controls was evaluated on Atherosclerotic lesion size (p=<0.05). Macrophage vitamin D receptor signaling inhibits atherosclerosis in mice, in part by suppressing the local renin-angiotensin system.
Synapse has enriched 10 related papers. Consider them for comparative context: